DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/hls5jn/acute_spinal_cord) has announced the addition of the "Acute Spinal Cord Injury - Pipeline Review, H1 2013" report to their offering.

'Acute Spinal Cord Injury - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Acute Spinal Cord Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Spinal Cord Injury.

Scope

- A snapshot of the global therapeutic scenario for Acute Spinal Cord Injury.

- A review of the Acute Spinal Cord Injury products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Acute Spinal Cord Injury pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

See the original post:
Research and Markets: Acute Spinal Cord Injury - Pipeline Review Report, H1 2013 Edition

Comments are closed.